MONICA MCLAUGHLIN: Open Payments
NPI 1780169623 · HOLLY SPRINGS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,167 in 32 payments from 11 companies in 2025. Trend: 2023 $1,027 · 2024 $1,165 · 2025 $1,167
Food & beverage: $1,167
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $290 |
| GlaxoSmithKline, LLC. | 2 | $244 |
| Novo Nordisk Inc | 5 | $199 |
| Amgen Inc. | 11 | $189 |
| PFIZER INC. | 3 | $122 |
| BeOne Medicines USA, Inc. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $23 |
| Boston Scientific Corporation | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $18 |
Products named: BREZTRI, REPATHA, Ozempic, PENMENVY, AREXVY, ZAVZPRET, OTEZLA, Wegovy.
Industry payments across NC — which companies pay providers there.
